CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-31 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +45,029 | 76,989 | ||
| 2021-12-31 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −23,033 | $62.35 | $1.4M | 53,956 |
| 2021-12-31 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Restricted Stock Units | −45,029 | 0 | ||
| 2021-12-31 | Hidalgo Medina Manuel Director | Grant or award · Deferred Share Units | +115.28 | $62.35 | $7K | 2,232.84 |
| 2021-12-16 | VESSEY RUPERT EVP, Research & Early Dev. | Sale | −6,198 | $61.99 | $384K | 45,060 |
| 2021-12-16 | VESSEY RUPERT EVP, Research & Early Dev. | Sale | −13,100 | $61.99 | $812K | 31,960 |
| 2021-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise | +8,792 | 55,756 | ||
| 2021-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −4,498 | $55.41 | $249K | 51,258 |
| 2021-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Option exercise · Restricted Stock Units | −8,792 | 17,584 | ||
| 2021-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Option exercise | +2,638 | 39,862 | ||
| 2021-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Shares withheld for taxes | −1,350 | $55.41 | $75K | 38,512 |
| 2021-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Option exercise · Restricted Stock Units | −2,638 | 5,275 | ||
| 2021-12-02 | Elkins David V EVP, Chief Financial Officer | Option exercise | +8,792 | 88,800 | ||
| 2021-12-02 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −4,498 | $55.41 | $249K | 84,302 |
| 2021-12-02 | Elkins David V EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −8,792 | 17,584 | ||
| 2021-11-24 | von Autenried Paul EVP, Chief Information Officer | Sale | −17,353 | $56.92 | $988K | 63,536.07 |
| 2021-11-23 | von Autenried Paul EVP, Chief Information Officer | Sale | −15,418 | $57.47 | $886K | 80,889.07 |
| 2021-11-22 | von Autenried Paul EVP, Chief Information Officer | Sale | −18,363 | $57.17 | $1.0M | 96,307.07 |
| 2021-09-30 | Arduini Peter J Director | Grant or award · Deferred Share Units | +549.27 | 33,648.42 | ||
| 2021-09-30 | Haller Julia A Director | Grant or award · Deferred Share Units | +549.27 | 10,870.47 |
Page 67 of 73 · 1,445 trades